Optase Dry Eye Intense Drops recalled over sterility concerns

Recall date

April 20, 2026

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Official notice title

SCOPE HEALTH recalls Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for Scope Health Inc., 79 M…

Recall number

D-0499-2026

FDA classification

Class II

Brand / firm

SCOPE HEALTH

Sold / distributed

Nationwide within the United States

Why it was recalled

Lack of Assurance of Sterility

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for Scope Health Inc., 79 Madison Ave., 8th Floor, New York, NY 10016, USA, NDC 72972-002-01.